Karl Swartling

Karl Swartling

Plus aucun poste en cours
61 ans
Finance
Health Technology
Health Services

Profil

Mr. Karl A. Swartling is a Chief Executive Officer at Stena Sessan AB. He is on the Board of Directors at Affibody AB. Mr. Swartling was previously employed as a Managing Director by Sjätte AP-fonden, a Managing Director by Sjätte AP-fonden (Private Equity), a Managing Director by Investor Growth Capital AB, a Deputy Director by Atlas Antibodies AB, a Non-Executive Director by GHP Specialty Care AB, and a Principal by Mckinsey & Co., Inc. (Munich).
He also served on the board at Aerocrine AB, Cambio Healthcare Systems AB, Cellectricon AB, Global Health Partner Ltd., KTH Holding AB, Mando AB, Newron Sweden AB, PocketMobile Communications AB, Sörman Intressenter AB and Tobii AB. He received his MBA from Stockholm School of Economics.

Postes actifs de Karl Swartling

SociétésPosteDébut
Directeur/Membre du Conseil -

Anciens postes connus de Karl Swartling

SociétésPosteFin
Directeur Général 01/03/2019
Directeur Général 01/03/2019
President 21/01/2012
AEROCRINE AB Directeur/Membre du Conseil 16/11/2011
Mckinsey & Co., Inc. (Munich)
Corporate Officer/Principal -
Voir l'expérience en détail de Karl Swartling

Formation de Karl Swartling

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

74

Relations au 1er degré

18

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées18

Electronic Technology

Commercial Services

Health Technology

Finance

Finance

Consumer Services

Health Technology

Health Services

Health Services

Electronic Technology

Health Technology

Technology Services

Finance

Health Services

Technology Services

Commercial Services

Finance

Mckinsey & Co., Inc. (Munich)

  1. Bourse
  2. Insiders
  3. Karl Swartling
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT